Percutaneous penetration modifiers and formulation effects

International Journal of Pharmaceutics

Volumn 386, Issue 1-2, 2010, Pages 42-51

  Kaushik, Diksha ^a   Costache, Aurora ^b   Michniak Kohn, Bozena ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Enhancers; Modifier ratio; Penetration modifiers; Retardants; Stratum corneum

Indexed keywords

3 DODECANOYLOXAZOLIDIN 2 ONE; ALCOHOL; CERAMIDE; DIETHYLTOLUAMIDE; DIMETHYL N (2 METHOXYCARBONYLBENZENESULFONYL)IMINOSULFURANE; DIMETHYL N (4 BROMOBENZOYL)IMINOSULFURANE; LAUROCAPRAM; MACROGOL 400; PENETRATION ENHANCING AGENT; PROPYLENE GLYCOL; SOLVENT; TERT BUTYL 1 DODECYL 2 OXOAZEPAN 3 YL CARBAMATE; UNCLASSIFIED DRUG; WATER;

ADULT; ANALYTIC METHOD; ARTICLE; CADAVER; CHEMICAL INTERACTION; CHEMICAL MODEL; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; SKIN PERMEABILITY; SOLUBILITY; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; AZEPINES; CADAVER; CARBAMATES; CERAMIDES; CHEMISTRY, PHARMACEUTICAL; DEET; DRUG COMPOUNDING; ETHANOL; HUMANS; HYDROGEN BONDING; INSECT REPELLENTS; KINETICS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; OXAZOLIDINONES; PERMEABILITY; PHARMACEUTIC AIDS; POLYETHYLENE GLYCOLS; PROPYLENE GLYCOL; SKIN; SKIN ABSORPTION; SOLVENTS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFUR COMPOUNDS; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 74149083789     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.10.052     Document Type: Article

References (41)

1. Abraham M.H., Martins F., and Mitchell R.C. Algorithms for skin permeability using hydrogen bond descriptors: the problem of steroids. J. Pharm. Pharmacol. 49 (1997) 858-865
2. Andega S., Kanikkannan N., and Singh M. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J. Control. Release 77 (2001) 17-25
3. Asbill C.S., El-Kattan A.F., and Michniak B. Enhancement of transdermal drug delivery: chemical and physical approaches. Crit. Rev. Ther. Drug Carrier Syst. 17 (2000) 621-658
4. Babu R.J., and Pandit J.K. Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin. Drug Deliv. 12 (2005) 165-169
5. Baker Jr. E.L., Warren M., Zack M., Dobbin R.D., Miles J.W., Miller S., Alderman L., and Teeters W.R. Epidemic malathion poisoning in Pakistan malaria workers. Lancet 1 (1978) 31-34
6. Batheja P., Kaushik D., Hu L., and Michniak-Kohn B.B. Transdermal iontophoresis. Drug Deliv. (2007) 46-49
7. Batheja P., Song Y., Wertz P., and Michniak-Kohn B. Effects of growth conditions on the barrier properties of a human skin equivalent. Pharm. Res. 26 (2009) 1689-1700
8. Briassoulis G., Narlioglou M., and Hatzis T. Toxic encephalopathy associated with use of DEET insect repellents: a case analysis of its toxicity in children. Hum. Exp. Toxicol. 20 (2001) 8-14
9. Fincher T.K., Yoo S.D., Player M.R., Sowell Sr. J.W., and Michniak B.B. In vitro evaluation of a series of N-dodecanoyl-l-amino acid methyl esters as dermal penetration enhancers. J. Pharm. Sci. 85 (1996) 920-923
10. Ghose A., Viswanadhan V.N., and Wendoloski J.J. Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragment methods: an analysis of A log P and C log P methods. J. Phys. Chem. A 102 (1998) 3762-3772
11. Godwin D.A., and Michniak B.B. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev. Ind. Pharm. 25 (1999) 905-915
12. Hadgraft J., Peck J., Williams D.G., Pugh W.J., and Allan G. Mechanisms of action of skin penetration enhancers/retarders: azone and analogues. Int. J. Pharm. 141 (1996) 17-25
13. Halgren T. Merck molecular force field. I Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 17 (1996) 490-519
14. Heard C.M., and Screen C. Probing the permeation enhancement of mefenamic acid by ethanol across full-thickness skin, heat-separated epidermal membrane and heat-separated dermal membrane. Int. J. Pharm. 349 (2008) 323-325
15. Hoogstraate A., Verhoef J., Brussee J., IJzerman A.P., Spies F., and Bodde H.E. Kinetics, ultrastructural aspects and molecular modelling of transdermal peptide flux enhancement by N-alkylazacycloheptanones. Int. J. Pharm. 76 (1991) 37-47
16. max. J. Control. Release 136 (2009) 117-124
17. Kandimalla K., Kanikkannan N., Andega S., and Singh M. Effect of fatty acids on the permeation of melatonin across rat and pig skin in-vitro and on the transepidermal water loss in rats in-vivo. J. Pharm. Pharmacol. 51 (1999) 783-790
18. Kaushik D., Batheja P., Kilfoyle B., Rai V., and Michniak-Kohn B. Percutaneous permeation modifiers: enhancement versus retardation. Expert Opin. Drug Deliv. 5 (2008) 517-529
19. Kim N., El-Khalili M., Henary M.M., Strekowski L., and Michniak B.B. Percutaneous penetration enhancement activity of aromatic S,S-dimethyliminosulfuranes. Int. J. Pharm. 187 (1999) 219-229
20. Lavon I., and Kost J. Ultrasound and transdermal drug delivery. Drug Discov. Today 9 (2004) 670-676
21. Leo A.J., Hansch C., and Elkins D. Partition coefficients and their uses. Chem. Rev. 71 (1971) 525-616
22. Lewis D., and Hadgraft J. Mixed monolayers of dipalmitoylphosphatidylcholine with azone or oleic acid at the air-water interface. Int. J. Pharm. 65 (1990) 211-218
23. Lien E.J., and Gao H. QSAR analysis of skin permeability of various drugs in man as compared to in vivo and in vitro studies in rodents. Pharm. Res. 12 (1995) 583-587
24. Mancini A.J. Skin. Pediatrics 113 4 Suppl. (2004) 1114-1119
25. Meiden V.M., Al-Khalili M., and Michniak B.B. Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers. Int. J. Pharm. 264 (2003) 73-83
26. Nokhodchi A., Shokri J., Dashbolaghi A., Hassan-Zadeh D., Ghafourian T., and Barzegar-Jalali M. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int. J. Pharm. 250 (2003) 359-369
27. Prausnitz M.R. Microneedles for transdermal drug delivery. Adv. Drug Deliv. Rev. 56 (2004) 581-587
28. Purdon, C., 2005. Synthesis and evaluation of aminocaprolactam derivatives as novel skin penetration retarders. Ph.D. Thesis. College of Pharmacy, University of South Carolina, Columbia.
29. Potts R.O., and Guy R.H. Predicting skin permeability. Pharm. Res. 9 (1992) 663-669
30. Potts R.O., and Guy R.H. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res. 12 (1995) 1628-1633
31. Sarigullu Ozguney I., Yesim Karasulu H., Kantarci G., Sozer S., Guneri T., and Ertan G. Transdermal delivery of diclofenac sodium through rat skin from various formulations. AAPS PharmSciTech 7 (2006) 88
32. Schlumpf M., Cotton B., Conscience M., Haller V., Steinmann B., and Lichtensteiger W. In vitro and in vivo estrogenicity of UV screens. Environ. Health Persp. 109 (2001) 239-244
33. Sintov A.C., Zhang P.J., and Michniak-Kohn B.B. Cutaneous biotransformation of N-(4-bromobenzoyl)-S, S-dimethyliminosulfurane and its product, 4-bromobenzamide, leading to percutaneous penetration enhancement of drugs: initial evidence using hydrocortisone. J. Control. Release 133 (2009) 44-51
34. Song Y., Xiao C., Mendelsohn R., Zheng T., Strekowski L., and Michniak B. Investigation of iminosulfuranes as novel transdermal penetration enhancers: enhancement activity and cytotoxicity. Pharm. Res. 22 (2005) 1918-1925
35. Strekowski L., Henary M., Kim N., and Michniak B.B. N-(4-bromobenzoyl)-S, S-dimethyliminosulfurane, a potent dermal penetration enhancer. Bioorg. Med. Chem. Lett. 9 (1999) 1033-1034
36. Valenta C., and Dabic T. Effect of urea and pantothenol on the permeation of progesterone through excised rat skin from polymer matrix systems. Drug Dev. Ind. Pharm. 27 (2001) 57-62
37. Wertz P.W. Epidermal lipids. Semin. Dermatol. 11 (1992) 106-113
38. Williams A., and Barry B.W. Chemical permeation enhancement. In: Touitou E., and Barry B.W. (Eds). Enhancement in Drug Delivery (2006), CRC Press
39. Williams A.C., and Barry B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 56 (2004) 603-618
40. Wong T.W., Chen C.H., Huang C.C., Lin C.D., and Hui S.W. Painless electroporation with a new needle-free microelectrode array to enhance transdermal drug delivery. J. Control. Release 110 (2006) 557-565
41. Wotton P.K., Møllgaard B., Hadgraft J., and Hoelgaard A. Vehicle effect on topical drug delivery. III. Effect of azone on the cutaneous permeation of metronidazole and propylene glycol. Int. J. Pharm. 24 (1985) 19-26